Navigation Links
Age is not a key factor in cancer survival, but clinical trials exclude older patients
Date:11/6/2008

Age is not an independent factor in cancer survival rates and should not influence decisions about how to treat older patients, according to a study in the November issue of IJCP, the Independent Journal of Clinical Practice.

A team of hospital and University-based researchers from Barcelona, Spain, carried out a detailed study of more than 200 patients diagnosed with cancer.

"We found that there were a number of factors that influence survival rates including physical quality of life and how far the cancer had spread but age was not one of them" says lead researcher Dr Eva Domingo from Hospital Vall d'Hebron.

"Despite this fact, and the challenges that clinicians face from an ageing population, there has been little research into how to treat older cancer patients, who often have complex medical needs because of other health issues.

"They have been systematically excluded from clinical trials for cancer treatments. Although 60 per cent of cancers occur in patients over 65, their participation in clinical trials does not exceed 25 per cent.

"This has made it difficult to predict how older patients will tolerate and respond to the latest cancer treatments and has provided an obstacle to making evidence-based clinical decisions."

Dr Domingo and her colleagues teamed up with researchers from the University of Barcelona to look at 224 patients diagnosed with cancerous tumours.

The patients ranged from 32 to 92 years of age and three-quarters of them were male. Thirty-nine per cent of the patients were under 65 and 61 per cent were 65 or over.

The most common tumours were respiratory (43 per cent) and gastrointestinal (29 per cent). 42 per cent of the patients had a localised tumour.

Just under two-thirds of the patients (62 per cent) died during the one-year follow-up period.

The data from each patient, which included body mass index and quality of life scores as well as various clinical tests, was subjected to a detailed analysis.

This showed that there were four independent factors that played a significant role in predicting whether a patient survived. These were:

Metastatic dissemination, which measures how widely the cancer has spread. The level of functional impairment the patient experienced, as measured by the Karnofsky Perfomance Status Scale. The patient's physical quality of life, as measured by the eight criteria on the Short Form 36 questionnaire. Serum albumin levels, a major protein that is produced in the liver and is essential for maintaining pressure in the vascular system.

Patients had better survival rates if they had a good physical quality of life and fewer problems with functional impairment. High serum albumin levels were also important, as were a lack of metastatic dissemination.

"The patient's age was not an independent factor that predicted how likely they were to survive cancer" stresses Dr Domingo. "Because of this, age, in itself, should not be used to limit diagnostic or therapeutic decisions."

The number of older cancer patients is rising as the worldwide population ages. But not enough it being done to meet their needs, argue the authors.

"Consciously or unconsciously, age often becomes a decisive element when diagnostic or therapeutic strategies are designed" says Dr Domingo.

"Older people tend to have more complex health needs, such as other illnesses, and that is one of the reasons that has frequently been put forward for not treating their cancers aggressively. However our study found that comorbidity, like age, was much less significant than factors like physical quality of life.

"Other reasons given include the limited long-term benefits, compared with younger patients, and the lack of financial, logistical and social support."

The authors hope that their research will reduce the focus that other clinicians put on age when they treat older patients with cancer.

"We would like to see less decisions taken on the basis of age and more research that explores the complex needs of older people, so that they can be treated more effectively and enjoy a better quality of life" concludes Dr Domingo.


'/>"/>

Contact: Annette Whibley
wizard.media@virgin.net
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Age, race are among factors that influence carotid-surgery success
2. The Age Factor on the Campaign Trail: When the Going Gets Tough, the Tough Keep Moving
3. Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Risk Factors
4. Study reveals factors of exceptional health in old age
5. Latest Pistachio Study Reveals Significant Reduction in Markers of Inflammation - an Emerging Risk Factor in Heart Disease
6. Study Reveals Factors of Exceptional Health in Old Age
7. A new relationship between brain derived neurotrophic factor and inflammatory signaling
8. Socioeconomic and treatment factors affect non-Hodgkin lymphoma patients survival
9. MultiVu Video Feed: NEW RESEARCH PUBLISHED IN THE AMERICAN JOURNAL OF CLINICAL NUTRITION FINDS PISTACHIOS IMPROVE RISK FACTORS FOR HEART DISEASE
10. New discovery about growth factor can be breakthrough for cancer research
11. Newly-defined factors may prevent postpartum smoking relapse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Revolution for Truth has organized the ... parental rights and civil liberties, and to restore transparency within government agencies responsible ... with a press conference taking place Friday morning calling on President Trump to ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... software and services, is proud to announce it has joined the National Association ... representing the interests of chronically ill, disabled, and dying Americans of all ages ...
(Date:3/28/2017)... Pittsburgh, PA (PRWEB) , ... March 28, 2017 ... ... built for and by physicians, announced today the launch of a free, public-facing ... The Via Cost Analyzer (VCA) was developed to provide comparative information to patients, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, ... of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to ... developed in association with efforts by the American College of Surgeons, U.S. Department ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , United Kingdom and  BOSTON , March ... provider Linguamatics today announced a partnership ... . The agreement allows pharmaceutical companies to extract ... I2E text mining technology. ... 18 of the top 20 global pharmaceutical companies. ...
(Date:3/28/2017)... Calif. , March 28, 2017  AcelRx ... focused on the development and commercialization of innovative ... announced that the European Medicines Agency (EMA) has ... tablet, 30 mcg) Marketing Authorisation Application (MAA) has ... the MAA is underway. The MAA for ARX-04 ...
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
Breaking Medicine Technology: